Colonoscopy, Biomarkers, and Targeted Therapy in Colorectal Cancer

被引:4
作者
Effendi, Y. S. Rustam [1 ,2 ]
机构
[1] Univ Sumatera Utara, Adam Malik Hosp, Pirngadi Hosp, Dept Internal Med,Fac Med, Medan, Indonesia
[2] Columbia Asia Hosp, Jl Listrik 2A, Medan 20112, Indonesia
关键词
Colonoscopy; colorectal cancer; biomarkers; cancer stem cells; targeted therapy; STEM-CELLS; PROGNOSIS; INSTABILITY; GUIDELINES; DIAGNOSIS; MICRORNAS; MARKERS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This review highlights the most versatile diagnostic test of colonoscopy for CRC. It remains the gold standard diagnostic tools for CRC, and to prevent CRC by screening and removing the polyp or premalignant lesions. This work also provides the most promising biomarkers, which highlights the application of the novel biomarkers in conjunction with clinical and pathologic features have allowed for more individualized approaches and targeted therapy to patients with CRC. CRC is the third most common cancer diagnosed, and the second leading cause of cancer-related deaths worldwide. With a population totaling 273,523,621 people, Indonesia has an estimated of 396,914 new cases of all cancers and 234,511 cancer-related deaths. Among those cancer cases, an estimated of 34,189 new CRC cases and 17,786 CRC deaths occurred in 2020. Most of CRC cases were located in the rectum compared to those in the distal colon or proximal colon. Clinical signs, symptoms and therapeutic approaches vary, depending on the stage and the location of CRC. Those cancer locations are different in terms of their associated molecular alterations. Biomarker tests of tumor tissue from colonoscopy biopsy can help doctors to select a specific CRC treatment, and the tests can be used to determine prognostic value, predictive factors and the targeted therapy. Targeted therapies are recommended for advanced or mCRC patients with KRAS/NRAS/BRAF mutated or wild-type tumors, HER2-amplified tumors, and NTRK gene fusion-positive, while immunotherapy is only offered for tumor with MSI-High (dMMR) status. The biomarkers and targeting approaches against colorectal CSCs are being developed and will be quite challenging.
引用
收藏
页码:476 / 486
页数:11
相关论文
共 50 条
  • [31] Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer
    Underwood, Patrick W.
    Ruff, Samantha M.
    Pawlik, Timothy M.
    CELLS, 2024, 13 (03)
  • [32] mirSNPs as Potential Colorectal Cancer Biomarkers: A Systematic Review
    dos Santos, Katiusse Alves
    de Sousa, Lourdes Maria Costa Alves
    de Souza, Karla Simone Costa
    Amigo, Olalla Maronas
    Luchessi, Andre Ducati
    Silbiger, Vivian Nogueira
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
  • [33] Colorectal cancer screening with colonoscopy
    Pereyra, Lisandro
    Gomez, Estanislao J.
    Mella, Jose M.
    Cimmino, Daniel G.
    Boerr, Luis A.
    MEDICINA-BUENOS AIRES, 2013, 73 (06) : 567 - 572
  • [34] MicroRNAs in Colon and Rectal Cancer - Novel Biomarkers from Diagnosis to Therapy
    Yang, Ying
    Meng, Wen-Jian
    Wang, Zi-Qiang
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2020, 20 (08) : 1211 - 1226
  • [35] Symptoms associated with finding colorectal cancer during colonoscopy
    Pullens, Hendrikus J. M.
    Laheij, Robert J. F.
    Vleggaar, Frank P.
    van Oijen, Martijn G. H.
    Siersema, Peter D.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (11) : 1295 - 1299
  • [36] Biomarkers for Stratification in Colorectal Cancer: MicroRNAs
    Fadaka, Adewale Oluwaseun
    Pretorius, Ashley
    Klein, Ashwil
    CANCER CONTROL, 2019, 26 (01)
  • [37] Epigenetic biomarkers in colorectal cancer diagnostics
    Rawson, James B.
    Bapat, Bharati
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2012, 12 (05) : 499 - 509
  • [38] DNA methylation based biomarkers in colorectal cancer: A systematic review
    Lam, Kevin
    Pan, Kathy
    Linnekamp, Janneke Fiona
    Medema, Jan Paul
    Kandimalla, Raju
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2016, 1866 (01): : 106 - 120
  • [39] The Diagnostic, Prognostic, and Predictive Potential of MicroRNA Biomarkers in Colorectal Cancer
    Toiyama, Yuji
    Goel, Ajay
    CURRENT COLORECTAL CANCER REPORTS, 2012, 8 (01) : 22 - 31
  • [40] Circulating non-coding RNAs as new biomarkers and novel therapeutic targets in colorectal cancer
    Yang, L.
    Zhang, X.
    Hu, G.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (11) : 2220 - 2236